WKL Wolters Kluwer NV

Wolters Kluwer Helps Improve Patient Education and Boost HCAHPS Scores by Adding Quizzing to the Patient Teaching Content Set in Lippincott Advisor

Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, today announced the addition of an innovative quizzing component for its recently released Patient Teaching Navigator add-on to Lippincott Advisor. By helping bedside clinicians more effectively communicate with and educate patients and families about their hospitalization and treatments, Lippincott Advisor Patient Teaching Navigator increases patient satisfaction and, subsequently, Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores.

Lippincott Advisor provides immediate evidence-based answers to clinicians’ most pressing care-related questions. Written by nurses, for nurses, Lippincott Advisor is an expanding collection of more than 16,000 evidence-based entries and patient teaching handouts that cover diseases and conditions, diagnostics tests, signs and symptoms, treatments and more – all accessible quickly and easily via any Internet-enabled device including smartphones and tablets.

In response to the growing emphasis on patient education, Lippincott Advisor was enhanced in February 2016 with the addition of Patient Teaching Navigator, an efficient and standardized approach to educating nurses and clinicians on exactly what to say to patients. It also provides guidance on assessing and identifying patients who may present challenges to customary teaching strategies. The newly added Quizzing feature takes that guidance a step further, leveraging quizzes to validate and reinforce clinicians’ knowledge of learning principles.

Patient education has a significant impact on HCAHPS scores. It is directly linked to five survey questions and influences responses to several others. With these scores published on the Hospital Compare website and with survey data used to generate hospital star ratings, ignoring patient education carries substantial risk. HCAHPS results are also tied to 30% of the total performance score used to set value-based purchasing reimbursements.

“Educating patients to ensure they are fully prepared to care for themselves after discharge is a key strategy for improving HCAHPS scores. The more comfortable clinicians are with this responsibility, the more likely they are to carry it out effectively,” said Anne Woods, DNP, RN, CRNP, ANP-BC, AGACNP-BC, Chief Nurse, Health Learning, Research & Practice, Wolters Kluwer. “Beyond scores and rankings, Lippincott Advisor also enables evidence-based practice at the bedside, empowering clinicians with the knowledge, tools and resources needed to drive improvements in patent safety and care outcomes and help advance clinicians in their journey to clinical excellence.”

Part of the Lippincott Solutions suite, Lippincott Advisor is available as a group subscription to hospitals and other healthcare facilities. It will be showcased in the Wolters Kluwer booth #613 at the American Nurses Credentialing Center (ANCC) National Magnet® 2016 Conference taking place October 5-7 in Orlando, FL.

Follow Lippincott Solutions on Twitter @NurseSolutions.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

EN
05/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Wolters Kluwer NV

 PRESS RELEASE

Share Buyback Transaction Details July 17 – July 23, 2025

Share Buyback Transaction Details July 17 – July 23, 2025 PRESS RELEASE                                         Share Buyback Transaction Details July 17 – July 23, 2025 Alphen aan den Rijn – July 24, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 190,651 of its own ordinary shares in the period from July 17, 2025, up to and including July 23, 2025, for €26.6 million and at an average share price of €139.36. These repurchases are part of the share buyback program announced on Febru...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ASM: 2Q25 Preview, AI winner BE Semiconductor Industries: 2Q25 Preview, focus on advanced order intake CM.com: Preview 1H25 D'Ieteren: Belron $4.655bn TBL repriced 25bp lower PostNL: Preview 2Q25F; consensus released Wolters Kluwer: To divest Finance, Risk and Regulatory Reporting unit

 PRESS RELEASE

Wolters Kluwer to divest its Finance, Risk and Regulatory Reporting un...

Wolters Kluwer to divest its Finance, Risk and Regulatory Reporting unit PRESS RELEASE Wolters Kluwer to divest its Finance, Risk and Regulatory Reporting unit Alphen aan den Rijn – July 21, 2025 – Wolters Kluwer Financial & Corporate Compliance (FCC) announces today that it has signed a binding agreement to sell its Finance, Risk and Regulatory Reporting (FRR) unit to Regnology Group GmbH (Regnology) for an enterprise value of approximately €450 million, subject to closing conditions and contractual adjustments. The planned divestment will allow FCC to concentrate its efforts and invest...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch